HealthEquity Valuation
| HQY Stock | USD 103.64 1.73 1.70% |
At this time, the firm appears to be undervalued. HealthEquity retains a regular Real Value of $117.62 per share. The prevalent price of the firm is $103.64. Our model calculates the value of HealthEquity from evaluating the firm fundamentals such as return on equity of 0.0678, and Return On Asset of 0.0494 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that HealthEquity's price fluctuation is very steady at this time. Calculation of the real value of HealthEquity is based on 3 months time horizon. Increasing HealthEquity's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since HealthEquity is currently traded on the exchange, buyers and sellers on that exchange determine the market value of HealthEquity Stock. However, HealthEquity's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 103.64 | Real 117.62 | Hype 103.64 | Naive 104.62 |
The intrinsic value of HealthEquity's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence HealthEquity's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of HealthEquity helps investors to forecast how HealthEquity stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of HealthEquity more accurately as focusing exclusively on HealthEquity's fundamentals will not take into account other important factors: HealthEquity Total Value Analysis
HealthEquity is currently projected to have company total value of 9.53 B with market capitalization of 8.81 B, debt of 1.11 B, and cash on hands of 176.89 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the HealthEquity fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.53 B | 8.81 B | 1.11 B | 176.89 M |
HealthEquity Investor Information
About 98.0% of the company shares are owned by institutional investors. The book value of HealthEquity was currently reported as 24.84. The company has Price/Earnings To Growth (PEG) ratio of 0.92. HealthEquity had not issued any dividends in recent years. Based on the key measurements obtained from HealthEquity's financial statements, HealthEquity is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.HealthEquity Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. HealthEquity has an asset utilization ratio of 34.79 percent. This suggests that the Company is making $0.35 for each dollar of assets. An increasing asset utilization means that HealthEquity is more efficient with each dollar of assets it utilizes for everyday operations.HealthEquity Ownership Allocation
The majority of HealthEquity outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in HealthEquity to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in HealthEquity. Please pay attention to any change in the institutional holdings of HealthEquity as this could imply that something significant has changed or is about to change at the company. Please note that on August 13, 2025, Representative Lisa McClain of US Congress acquired under $15k worth of HealthEquity's common stock.HealthEquity Profitability Analysis
The company reported the last year's revenue of 1.2 B. Total Income to common stockholders was 96.7 M with profit before taxes, overhead, and interest of 842.97 M.About HealthEquity Valuation
Our relative valuation model uses a comparative analysis of HealthEquity. We calculate exposure to HealthEquity's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of HealthEquity's related companies.HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company was incorporated in 2002 and is headquartered in Draper, Utah. Healthequity operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 3688 people.
HealthEquity Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 88.8 M | |
| Quarterly Earnings Growth Y O Y | 0.7 | |
| Forward Price Earnings | 22.9358 |
Additional Tools for HealthEquity Stock Analysis
When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.